Statins Activate Human PPAR Promoter and Increase PPAR mRNA Expression and Activation in HepG2 Cells
Open Access
- 24 December 2008
- journal article
- research article
- Published by Hindawi Limited in PPAR Research
- Vol. 2008, 1-11
- https://doi.org/10.1155/2008/316306
Abstract
Statins increase peroxisome proliferator-activated receptor (PPAR) mRNA expression, but the mechanism of this increased PPAR production remains elusive. To examine the regulation of PPAR production, we examined the effect of 7 statins (atorvastatin, cerivastatin, fluvastatin, pitavastatin, pravastatin, rosuvastatin, and simvastatin) on human PPAR promoter activity, mRNA expression, nuclear protein levels, and transcriptional activity. The main results are as follows. (1) Majority of statins enhanced PPAR promoter activity in a dose-dependent manner in HepG2 cells transfected with the human PPAR promoter. This enhancement may be mediated by statin-induced HNF-4. (2) PPAR mRNA expression was increased by statin treatment. (3) The PPAR levels in nuclear fractions were increased by statin treatment. (4) Simvastatin, pravastatin, and cerivastatin markedly enhanced transcriptional activity in 293T cells cotransfected with acyl-coenzyme A oxidase promoter and PPAR/RXR expression vectors. In summary, these data demonstrate that PPAR production and activation are upregulated through the PPAR promoter activity by statin treatment.Keywords
This publication has 37 references indexed in Scilit:
- Peroxisome Proliferator Activated Receptors and Lipoprotein MetabolismPPAR Research, 2007
- Effects of Obesity on Lipid-Lowering, Anti-Inflammatory, and Antiatherosclerotic Benefits of Atorvastatin or Pravastatin in Patients With Coronary Artery Disease (from the REVERSAL Study)The American Journal of Cardiology, 2006
- Going nuclear in metabolic and cardiovascular diseaseJCI Insight, 2006
- Atorvastatin improves peroxisome proliferator-activated receptor signaling in cardiac hypertrophy by preventing nuclear factor-κB activationBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2005
- The effect of high glucose on NO and O2− through endothelial GTPCH1 and NADPH oxidaseLife Sciences, 2004
- Simvastatin modulates TNFα-induced adhesion molecules expression in human endothelial cellsLife Sciences, 2004
- New Evidence for Beneficial Effects of Statins Unrelated to Lipid LoweringArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect: Reduction of MRNA levels for interleukin-1β, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor α (PPARα) in primary endothelial cellsLife Sciences, 2000
- The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiationBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Design features and baseline characteristics of the LIPID (long-term intervention with pravastatin in ischemic disease) study: A randomized trial in patients with previous acute myocardial infarction and/or unstable angina pectorisThe American Journal of Cardiology, 1995